Twin SUBLIVAC Grasses Clinical Efficacy Study.

Trial Profile

Twin SUBLIVAC Grasses Clinical Efficacy Study.

Phase of Trial: Phase III

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Allergy immunotherapy (Primary)
  • Indications Allergic asthma; Grass pollen hypersensitivity; Rhinoconjunctivitis; Seasonal allergic rhinitis
  • Focus Registrational; Therapeutic Use
  • Sponsors HAL Allergy
  • Most Recent Events

    • 15 Sep 2009 Actual end date (1 Oct 2007) added as reported by
    • 15 Sep 2009 Status changed from active, no longer recruiting to completed as reported by
    • 23 Mar 2008 The expected completion date for this trial is now 1 Nov 2009, reported by Planned patient number also updated.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top